Dr Lal Pathlabs Limited – Stunning debut Share up 50%

Shares of Dr Pathlabs Limited listed at the BSE and NSE and made a stunning debut to be easily the best listing for the year 2015. The company had through a secondary offering sold 1.16 cr shares in a price band of Rs 540-550 with a discount of Rs 15 to retail investors. The company had allotted 34.80 lac shares to 15 anchor investors comprising of 25 entities at the top end of the band at Rs 550. The issue received excellent response and was subscribed 33.41 times with HNI’s subscribing their bucket 61.28 times.

The discovered price was Rs 717 on the BSE and Rs 720 on the NSE. The lows of the day were quite close to this discovered price at Rs 715.50 and Rs 711.15 respectively. The highs of the day were Rs 842.40 and 843.70. The weighted average was Rs 777.15 and Rs 778.44 significantly lower than the closing price of Rs 824.15 and Rs 834.50. This indicates that the price rise was in the latter half of the day. Apparently looking at the huge trading volumes of 271.87 lac shares or 2.34 times of the IPO size, one gets a feeling that somewhere people/traders went short during the day and this led to short covering and significant increase in traded volume.

Delivery volume at 55.50 lac shares was 20.41% of traded volume and a significant 47.84% of the IPO size. If one were to deduct the anchor portion from the same which has a lock in period of 30 days, the delivery percentage rises significantly to 68.35%. Just one name appears in the bulk trades list with Ashoka PTE buying 4.25 lac shares at 729.86 per share. Very clearly the share has gone into stronger hands and there seems to be some sort of liquidity squeeze on the counter. It’s good for some more price movement but valuations are certainly stretched at these levels.

Exchange  Open  High Low Close Net Change % Gain/loss Wt. Avg Volume Delivery  Del %age
BSE 717.00 842.40 715.50 824.15 274.15 49.85 777.15 4969365 932390 18.76
NSE 720.00 843.70 711.15 834.50 284.50 51.73 778.44 22217904 4617581 20.78
Total 27187269 5549971 20.41

All in all it’s been a super duper listing and with 50% gains on listing day no one can complain. It is a Christmas gift to investors who were lucky and they have made decent gains. Lucky investors from the retail category were allotted 20s shares at a discount of Rs 15 which means they paid Rs 10,700 for 20 shares and were able to sell them at the average price of Rs 777, a profit of Rs 242 or 45%. It sure is a great start.

With clearly the best left for the year end, hopes of money being left on the table will rise with coming issues in the new calendar year. Whether the promoter-merchant banker duo delivers or not will be seen in the next few issues.

Great start for Dr Lal Pathlabs.

Alkem Laboratories Limited – Great Debut Stock closes with gains of 31.5%

Shares of Alkem Laboratories Limited listed on the BSE and NSE and made a stunning debut. The company through a secondary offering had sold 128.53 lakh shares in a price band of Rs 1020-1050. The company had allotted 37.66 lac shares to 25 Anchor investors comprising of 47 entities at the top end of the price band at Rs 1,050.

The issue was well received and was subscribed an overall 44.29 times, with HNI’s subscribing their bucket 129.96 times. The issue was priced at Rs 1,050. The issue began trading with the discovered price of Rs 1,380. Thereafter it was in a narrow range with the high being Rs 1,410 and the low at Rs 1,355.40. The high made late in the afternoon and the low made in the morning were aberrations and the share traded throughout the day in a narrow range of Rs 1,370-1390. This kind of small range is uncharacteristic of issues in recent years. A share issued at Rs 1,050 and trading in a range of a mere 2% could be unheard of. The share at the end of the day had a weighted average of Rs 1,383.67 on the BSE and Rs 1,382.36 on the NSE.

Exchange  Open  High Low Close Net Change % Gain/loss Wt. Avg Volume Delivery  Del %age
BSE 1380.00 1410.00 1355.40 1381.45 331.45 31.57 1383.67 2437867 993473 40.75
NSE 1380.00 1413.70 1356.20 1381.00 331.00 31.52 1382.36 10984341 3797088 34.57
Total 13422208 4790561 35.69

There were no names on the buying or selling side of the issue even though a total of 1.34 cr shares or 1.04 times the IPO size was traded. The delivery volume at 47.90 lac shares was 35.69% of the traded volume and 37.27% of the IPO size. If one considers the delivery percentage on the IPO size minus the anchor portion the same rises to 52.72%. This is a high delivery portion and very clearly it appears that shares have gone into stronger hands. The possibility that share price may rise higher exists.

A successful issue where even though the allotment was poor, there was money for all including the leveraged investor. The discovered price which was also the weighted average and the closing price was significantly higher than the grey market price of Rs 250-260. The share closed with gains of Rs 330 or 31%.

One prays that merchant bankers and promoters realise that a decent asking price gives a disproportionate rise in demand for the issue. The calendar year is coming to an end and this was probably the last listing with Dr Lal for the calendar year 2015.

Narayana Hrudayalaya Limited – Subscribed 8.70 times

The secondary offering from Narayana Hrudayalaya (NH) was oversubscribed 8.70 times. The company through a secondary offering in a price band of Rs 245-250 planned to raise a shade over Rs 600 crs through the offering. It had allotted 73.57 lac shares to 15 anchor investors comprising of 25 entities at the top end of the band of Rs 250.

The issue was well supported by QIB’s who subscribed their bucket 24.43 times while the HNI bucket was subscribed 3.62 times. The response from this segment comprising of the leveraged investor was poor as the grey market premium fell. The margin payable for borrowing and then applying remained high and hence the lacklustre response. Time and again I have been maintaining that by allowing this category to apply one time the whole issue rather than one time the bucket size is distortion of demand. This demand distortion is detrimental to the primary market and there are umpteen examples where good issues having received excellent response have become a cropper simply because the cost of leverage could not be sustained.

The retail portion was subscribed 1.89 times.

The detailed subscription is given in the table below: –

Bucket Size Shares Applied for Times oversubscribed
QIB 4904660 119798760 24.43
HNI 3678495 13323420 3.62
Retail 8583154 16208820 1.89
Total 17166309 149331000 8.70
Subscribe to RSS Feed Follow me on Twitter!